Request for Proposals: Generic Drug Repurposing
Funds late-stage clinical trials repurposing generic drugs to treat neglected, high-burden diseases in low- and lower-middle-income countries.
Browse similar grants
This grant is no longer accepting proposals
Coefficient Giving has archived this opportunity.
Funder: Coefficient Giving
Due Dates: May 11, 2026
Funding Amounts: Up to $20 million total; no maximum per project; multiple awards expected.
Summary: Supports late-stage clinical trials repurposing generic drugs for new indications to address neglected, high-burden diseases in low- and lower-middle-income countries.
Description
This grant opportunity, offered by Coefficient Giving, aims to accelerate the development of new treatments for high-burden, neglected diseases by funding late-stage clinical trials that repurpose existing generic drugs. The initiative targets diseases prevalent in low- and lower-middle-income countries (LMICs), leveraging the established safety and accessibility of generic medicines to rapidly generate clinical evidence for new indications. By focusing on repurposed therapies, the program seeks to overcome commercial disincentives and bring impactful, affordable treatments to underserved populations.
